Year: 2012
Year: 2012
In accordance with Article 15 of the GMO Regulations S.I. No 500 of 2003, applicants proposing to carry out a Deliberate Release of GMOs for purposes other than placing on the market, are required to place an advertisement in a newspaper circulating in the area. This advertisement invites the public to make representations to the EPA in relation to the proposed deliberate release.
Year: 2012
Guidance document on Surrender, Cessation, Closure of licensed sites.
Year: 2012
This guidance sets out the Agency’s requirements on how licensees should establish and maintain trigger levels on storm water discharges from their sites. This guidance includes advice on baseline monitoring, result assessment in order to select appropriate parameters and trigger values and suitable response procedures.
Year: 2012
Historic_Landfill_Template_letter_PB_to_QP
Year: 2012
Historic Landfill Template Letter Qualified Person to Local Authority
Year: 2012
Additional information to be submitted with a notification for the contained use of a Class 3 GMM under the GMO (Contained Use) Regulations 2001 to 2010. This covers information required under Part A of the Fifth Schedule and further information for the assessment of the notification.
Year: 2011
BAT Guidance Note - Waste Sector (Transfer & Materials Recovery) - Dec 2011
Year: 2011
BAT Guidance Note - Waste Sector (Landfill) - Dec 2011
Year: 2011
The GMO Register Entry G0451-01 provides significant details of the clinical trial.
Year: 2011
This is the final report on the malaria vaccine trial. The report details an overview of the clinical trial and the methodology and results of the trial.
Year: 2011
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.
Year: 2011
Consent Conditions issued to Professor Samuel McConkey, Royal College of Surgeons in Ireland, to carry out a clinical trial on patients to assess the safety and immunogenicity of a new malaria vaccine, using two Genetically Modified Micro-Organisms (GMMs), at Beaumont Hospital in Dublin, from September 2011 to December 2012.
Year: 2011
There is a statutory requirement under Part A of the 5th Schedule of the Genetically Modified Organisms (Contained Use) Regulations, 2001 to 2010, to provide details of any biological committees or subcommittees.
Year: 2011
These schedules are an extract from the Waste Management Act 1996 as amended, detailing the disposal and recovery activities that require a waste licence.
Year: 2011
Additional information to be submitted with a notification for the contained use of a Class 1 / 2 GMM under the GMO (Contained Use) Regulations 2001 to 2010. This covers information required under Part A of the Fifth Schedule and further information for the assessment of the notification.
Year: 2011
Additional information to be submitted with a notification for the contained use of a GMO (GM Aminal/ GM Plant) under the GMO (Contained Use) Regulations 2001 to 2010. This covers information required under Part I of the Seventh Schedule and further information for the assessment of the notification. Please view Guidelines for those who plan to work with GM animals / GM plants.
Year: 2010
All documentation submitted in respect of this notification was taken into consideration by the EPA inspector in her report to the Board of the Agency.
Year: 2010
Consent Conditions G0362-01 issued to Applied Genetics Technologies Corporation, USA, to carry out a clinical trial on patients suffering from alpha-1 antitrypsin deficiency, using a Genetically Modified Micro-Organism (GMM). This trial did not proceed.
